Expert Discusses the Importance of C. Diff Awareness, Future Treatments

Debra Goff, PharmD, FIDSA, FCCP, infectious diseases specialist at the Ohio State University Wexner Medical Center, discusses Clostridioides difficile awareness and potential future treatments.

In a Pharmacy Times® interview, Debra Goff, PharmD, FIDSA, FCCP, infectious diseases specialist at the Ohio State University Wexner Medical Center and professor of Pharmacy Practice at the Ohio State University College of Pharmacy, reviews what makes Clostridioides difficile (C. diff) awareness critical, and highlights the work of the Peggy Lillis Foundation.

In this discussion, Goff covers the risk factors for contracting C. diff, current available treatments, and the future of C. diff treatment. She also details the efforts of the Peggy Lillis Foundation to raise awareness of this disease.